Page last updated: 2024-09-05

bis(diazo)benzidine and Hyperglycemia, Postprandial

bis(diazo)benzidine has been researched along with Hyperglycemia, Postprandial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Fang, Y; Ou, K; Wang, Q; Zeng, C1
Fang, Y; Ou, K; Shen, Q; Wang, Q; Zeng, C; Zhang, L1

Other Studies

2 other study(ies) available for bis(diazo)benzidine and Hyperglycemia, Postprandial

ArticleYear
5-Bromo-3,4-dihydroxybenzaldehyde attenuates endothelial cells injury from high glucose-induced damage.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: Glucose; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Interleukin-6; NF-kappa B; Reactive Oxygen Species; Tumor Necrosis Factor-alpha

2022
5-Bromo-3,4-dihydroxybenzaldehyde stabilizes diabetic retinal neurovascular units by inhibiting the inflammatory microenvironment.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 168

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Humans; Hyperglycemia; Interleukin-6; Mice; Retina; Tumor Necrosis Factor-alpha

2023